← back to search

Christopher M. Koth

Gene Therapy Laboratory · FR
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Biology, Computational biology, ATP-binding cassette transporter, Gating, Sodium channel, and Frizzled.
h-index
citations
751
works
10
NIH funding
primary concept
email

Recent publications

Disulfide-constrained Fabs overcome target size limitation for high-resolution single particle cryoEM
Nature Communications 2025cited by 3position: middledoi
Structural and functional diversity calls for a new classification of ABC transporters
FEBS Letters 2020cited by 282position: middledoi
Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin
Cell 2019cited by 184position: middledoi
A Flexible and Scalable High-Throughput Platform for Recombinant Membrane Protein Production
Methods in molecular biology 2019cited by 3position: lastdoi
A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells
Nature Chemical Biology 2018cited by 82position: middledoi
A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies
Scientific Reports 2018cited by 37position: middledoi
Publisher Correction: A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells
Nature Chemical Biology 2018cited by 1position: middledoi
Voltage-gated sodium channels viewed through a structural biology lens
Current Opinion in Structural Biology 2016cited by 34position: middledoi
Structural Analysis of Bacterial ABC Transporter Inhibition by an Antibody Fragment
Structure 2015cited by 39position: lastdoi
Novel Staphylococcal Glycosyltransferases SdgA and SdgB Mediate Immunogenicity and Protection of Virulence-Associated Cell Wall Proteins
PLoS Pathogens 2013cited by 86position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jian Payandeh · Exelixis (United States)4 papers (2016–2019) · 3 papers (2018–2019)Rami N. Hannoush · National University of Singapore2 papers (2018–2018) · 2 papers (2015–2018)Felipe de Sousa e Melo · Amgen (United States)2 papers (2018–2018)Susmith Mukund · Amgen (United States)2 papers (2018–2018) · 2 papers (2019–2025)Alexis Rohou · Imperial College London2 papers (2019–2025)Jawahar Sudhamsu · Gilead Sciences (United States)2 papers (2015–2025)Robert Piskol · Gene Therapy Laboratory2 papers (2018–2018)Christopher P. Arthur · University of Colorado Boulder2 papers (2019–2025)Zora Modrušan · Genetic Technologies (Australia)2 papers (2018–2018) · 2 papers (2018–2018)Thomas Clairfeuille · University of Queensland2 papers (2016–2019) · 2 papers (2018–2018)Yingnan Zhang · Georgia Institute of Technology2 papers (2018–2018)Yue Fu · Hangzhou Normal University2 papers (2018–2018)Hui Xu · Nanjing University of Chinese Medicine2 papers (2016–2019)Aaron H. Nile · Texas A&M University2 papers (2018–2018)Frédéric J. de Sauvage · Gene Therapy Laboratory2 papers (2018–2018)